Day One Biopharmaceuticals, Inc.
(DAWN - NASDAQ)
21,53 USD
📋 Profilo Aziendale

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers.

|